| Document |
Document Title |
|
WO/2024/086246A2 |
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions.
|
|
WO/2024/085848A1 |
The invention relates to the biodegradable, antifungal, anti-inflammatory and antibacterial biocomposite wound dressing based on polylactic acid (FLA) comprising cold-pressed hemp seed oil and cannabidiol (CBD) and the production method ...
|
|
WO/2024/054562A3 |
Disclosed are supramolecular hybrid hydrogels (SHH), wound dressings, comprising supramolecular hybrid hydrogels; and methods of treating wounds, including burns.
|
|
WO/2024/078282A1 |
The present invention particularly relates to a liquid dressing for promoting wound healing. The liquid dressing comprises the following components in percentage by weight: 1%-2% of monosilicic acid and 98%-99% of distilled water; and th...
|
|
WO/2024/073155A1 |
A composition comprising a hydrogel includes a polymer of formula (1), at least one repeating unit of which comprises norbomene. Methods of treating wounds and methods of encapsulating drugs and/or cells using such hydrogels are also dis...
|
|
WO/2024/068836A1 |
The present disclosure relates to haemostatic compositions comprising a biocompatible polymer, thrombin and fibrinogen and methods for the preparation of such compositions.
|
|
WO/2024/064336A1 |
A dressing including a top film, an adhesive layer positioned adjacent the top film closer to a user's skin when the bandage is in use, a hydrogel layer including a support layer, below the adhesive layer closer to the user's skin when t...
|
|
WO/2024/062499A1 |
The present invention discloses antimicrobial compositions and formulation thereof for coating the medical devices. The composition of the present invention comprises a supporting polymer, an antimicrobial agent, a film forming polymer, ...
|
|
WO/2024/057324A1 |
The present invention, in some aspects thereof, provides a plasma-activated liquid composition capable of in-situ gelation upon a stimulus, e.g., a change in temperature or a change in pH or induced by light. The plasma-activated liquid ...
|
|
WO/2024/059627A1 |
Provided herein are biopolymers comprising repeating polysaccharide units, preparations of biopolymers, and compositions and dressings comprising biopolymers, as well as methods of use.
|
|
WO/2024/026668A9 |
Disclosed in the present invention are an injectable hydrogel adhesive having both fast-curing and anti-swelling properties and a use. The injectable hydrogel adhesive comprises the following components in percentage by mass: 5%-20% of t...
|
|
WO/2024/048890A1 |
The present invention relates to pharmaceutical agents, cosmetics, medical devices, and the like, containing novel skin-lightening functional peptides. The present inventors found that the RMNE1 peptide of SEQ ID NO: 1 and a variant ther...
|
|
WO/2024/049361A1 |
The cannabinoid -based compositions according to this invention are developed to provide unique properties to help the blood clot, including the inhibition of bacterial infection. The aforementioned compositions comprise active substance...
|
|
WO/2023/086098A9 |
Disclosed are ocular sealant formulations and systems for treating ocular wounds. The ocular sealant formulations are administered to a subject by applying the sealant to a surface of the subject's eye. Also disclosed are methods of prep...
|
|
WO/2024/027979A1 |
The invention relates to a sprayable formulation based on natural raw materials for protecting against microorganisms and for the hydrophobisation of surfaces of medical products, in particular skin coverings.
|
|
WO/2024/023503A1 |
53 Abstract There is provided a liquid or gel composition for generating hydrogen peroxide. The composition comprises enzyme that is able to convert a substrate to release hydrogen peroxide; substrate for the enzyme; and polymer. The com...
|
|
WO/2024/022671A1 |
The present invention relates to a method for protecting the skin when removing bonded skin coverings.
|
|
WO/2022/264149A9 |
A hydrogel comprising a cross-linked or a non-crosslinked PVA/PVP mixed polymer hydrogel is provided, Further, articles comprising the hydrogel optionally including an active agent incorporated therewithin are also provided.
|
|
WO/2024/020135A1 |
An in vitro method of quantifying an estimated dosage of at least one endogenous component from a human placental membrane allograft to a subject in need thereof in vivo during a predetermined time period.
|
|
WO/2024/014795A1 |
The present invention relates to: a method for producing a hydrogel prepared from an extracellular matrix without a separate polymer support or a hydrogel precursor solution; a hydrogel produced therefrom; a sponge produced by freeze-dry...
|
|
WO/2024/011235A1 |
The present disclosure relates to compositions and methods for improving wound healing and tissue regeneration. More specifically, the present disclosure relates to compositions, and methods of using such compositions, that direct the im...
|
|
WO/2024/008965A1 |
The present invention provides a hydrogel comprising hydroxyethyl cellulose (HEC) and bacteriophages.
|
|
WO/2024/003602A1 |
The present disclosure relates to bioadhesives, their method of preparation and uses thereof. Taking in consideration the mussels bioinspired adhesion mechanism, the present disclosure is related to the fabrication of a bioadhesive compo...
|
|
WO/2023/249449A1 |
The present application relates to a pharmaceutical composition for wound treatment . Specifically, the present application concerns a composition including a wound-coating material and chemokine-adsorbing particles to absorb inflammator...
|
|
WO/2023/231050A1 |
The present invention relates to a tough antibacterial hydrogel dressing and a preparation method therefor. According to the hydrogel dressing, gel formation is based on a hydrogen bond effect of a gel-forming framework such as polyvinyl...
|
|
WO/2023/231049A1 |
An antibacterial dressing for promoting scarless healing of wounds and a preparation method therefor. The dressing consists of the following components: 0.05-0.1 parts by weight of a hyperbranched polylysine anti-scar compound, 0.1-2.0 p...
|
|
WO/2023/231051A1 |
The present invention relates to an antibacterial, antioxidant hydrogel dressing for treating diabetic wounds and a preparation method therefor. The dressing is obtained by cross-linking epoxy groups in a gel-forming framework polymer co...
|
|
WO/2023/230285A1 |
Disclosed herein include methods of killing or preventing growth of one or more biological contaminants and/or pathogens on or in a subject.
|
|
WO/2023/230213A1 |
The present application relates to keratin protein extracts, compositions, methods and uses thereof. In some embodiments, the keratin protein extract is a beta-keratin extract. In some embodiments, the compositions are beta-keratin compo...
|
|
WO/2023/216495A1 |
Provided are a dynamic antibacterial hydrogel based on a natural receptor ligand recognition effect, a preparation method and use, which belong to the field of biomedical materials. First, a modification material is used to modify the li...
|
|
WO/2023/215453A1 |
A medical patch can comprise a biocompatible substrate and a dry hydrogel precursor layer on the substrate, the dry hydrogel precursor layer comprising an electrophilic-hydrogel precursor having a plurality of electrophilic functional gr...
|
|
WO/2023/206055A1 |
Provided are a modification and the use of silk fibroin. Calcium in silk fibroin or fibroin fibers is partially or completely removed, so as to obtain the modified silk fibroin with a broad-spectrum antioxidant effect. A method for prepa...
|
|
WO/2023/208303A1 |
A cellulose composition for sealing around a stoma, an ostomy device or an accessory for an ostomy device comprising the composition, and a method for sealing around a stoma. The composition comprises a continuous phase and a discontinuo...
|
|
WO/2023/212126A1 |
The present invention provides a soft tissue composite. The soft tissue composite comprises a first collagen fiber bundle of a first soft tissue isolated from a first donor and a polymeric material, and the first collagen fiber bundle in...
|
|
WO/2023/205051A1 |
Compositions, methods, and applications for single component systems for the formation of in situ hydrogels are described. The single component systems are effective for forming stable, single solutions containing precursors providing bo...
|
|
WO/2023/197700A1 |
The present disclosure provides a preparation method for a wound dressing, a wound dressing and use, and relates to the technical field of medical materials. The preparation method for the wound dressing comprises: using polyvinyl alcoho...
|
|
WO/2023/198959A1 |
The invention relates to an adhesive body dressing (10) comprising a backing layer (B) and a hydrocolloid adhesive layer (H), the backing layer (B) is a film layer or a foam layer comprising a first side (B1) and a second side (B2), the ...
|
|
WO/2023/198958A1 |
The invention relates to an adhesive body dressing (10) comprising a backing layer (B) and a hydrocolloid adhesive layer (H). The hydrocolloid adhesive layer (H) is provided directly on the first side (B1) of backing layer (B). The hydro...
|
|
WO/2023/194821A1 |
A polypseudorotaxane hydrogel (PPRh) is converted into a purified polypseudorotaxane hydrogel (pPPRh). The PPRh includes axles of a polymer that includes ethylene oxide; alpha-cyclodextrin (a-CD) threaded on the axles (threaded a-CD); an...
|
|
WO/2023/194587A1 |
The present invention relates to hydrogels, methods of making them, their use in the treatment of eye disorders and as bandage contact lenses. The present invention also provides modified poly-ε-lysine polymers and methods of making them.
|
|
WO/2023/196852A1 |
A jammed gel bioink comprises a self-assembling peptide solution comprising a self-assembling peptide, and a cell solution comprising living cells and a cell culture medium. The self-assembling peptide solution is extruded to form an obj...
|
|
WO/2023/172751A1 |
Device and methods for treating wounds or surgical sites are provided. The devices and methods include use of antifibrinolytic agents such as tranexamic acid to reduce exudate and improve wound healing. Embodiments provide for the timed ...
|
|
WO/2023/167123A1 |
This method for preparing a medical hydrogel derived from a chitosan derivative, in which aldonic acid is bonded to the amino group of the glucosamine unit of chitosan by dehydration condensation, comprises a step for performing high-pre...
|
|
WO/2023/146490A1 |
The present invention discloses a wound dressing (8) and the production method thereof that is made of a polymer selected from the group of polyvinyl alcohol (PVA), polylactic (PLA) polylactic (PLA), polyglycolic acid (PGA), poly lactic-...
|
|
WO/2023/139215A1 |
The present invention relates to a hydrogel comprising dendritic polyglycerol units and polyether units. The dendritic polyglycerol units correspond to general formula (I). They comprise a dendritic polyglycerol core having terminal hydr...
|
|
WO/2023/139492A1 |
The present invention relates to the field of the formulation of bioactive compounds. More specifically, it relates to the use of wet silica-based polymers obtained with the sol-gel technology for the incorporation and prolonged release ...
|
|
WO/2023/119235A1 |
A dissolvable medical device for placing on the outer exposed surface of the eye to heal the corneal wound comprising of: a polymeric film has sufficient dimensions to substantially cover a cornea when applied to an eye, wherein the poly...
|
|
WO/2023/119231A1 |
A dissolvable medical device for protecting a corneal surface and providing lubrication and hydration to the corneal surface during ophthalmic surgery comprising: a polymeric film has sufficient dimensions to substantially cover a cornea...
|
|
WO/2023/119228A1 |
A dissolvable medical device for placing on the outer exposed surface of the eye to deliver a drug to the eye comprising: a polymeric film has sufficient dimensions to substantially cover a cornea when applied to an eye, wherein the poly...
|
|
WO/2023/118370A1 |
The invention relates to a synthetic, particulate wound dressing (10) in the form of bulk material (12) with particles (14) of a maximum diameter (d) of 5 mm, each particle (14) having a porosity of more than 80% and each particle compri...
|
